CLYM Climb Bio, Inc. - Common Stock
$10.10
Price · May 20, 2026
Fundamentals as of May 7, 2026
52W Range
$1–$12
79% of range
Analyst Rating
STRONG BUY
19 analysts
Price Target
$20
+100% upside
P/E (TTM)
-4.5
ROE
-34.6%
Net Profit Margin
—
CLYM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$10.10
Market Cap
$191M
P/E (TTM)
-4.5
EPS (TTM)
$-0.88
Revenue (TTM)
—
Div Yield
—
ROE
-34.6%
Debt/Equity
—
52W Range
$1 – $12
CLYM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
$-0.88
2021-12-31
→
2025-12-31
Free Cash Flow
$-55M
2024-12-31
→
2025-12-31
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
CLYM
Peer Median
P/E (TTM)
-4.5
24.6
P/B
1.2
2.9
Price / FCF
-3.5
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
CLYM
Peer Median
ROA
-31.1%
-36.3%
ROE
-34.6%
-49.4%
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
CLYM
Peer Median
Current Ratio
15.2
5.6
Quick Ratio
14.5
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
CLYM
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
CLYM
Peer Median
CLYM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
19 analysts
- Strong Buy 9 47.4%
- Buy 9 47.4%
- Hold 1 5.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
12 analysts · 2026-05-17
Median
$19.50
← Below all targets
$10.10
Low
$16.00
High
$26.00
Median target
$19.50
+93.1%
Mean target
$20.17
+99.7%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.03%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.20 | $-0.27 | 0.07% |
| Dec. 31, 2025 | $-0.26 | $-0.20 | -0.06% |
| Sept. 30, 2025 | $-0.19 | $-0.15 | -0.04% |
| June 30, 2025 | $-0.13 | $-0.19 | 0.06% |
| March 31, 2025 | $-0.31 | $-0.15 | -0.16% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CLYM | $191M | -4.5 | — | — | -34.6% | — |
| SLDB | $445M | -2.8 | — | — | -79.5% | — |
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | — |
| EIKN | — | — | — | — | — | — |
| TRAX | — | — | — | — | — | — |
| CADL | $310M | -7.8 | — | — | -53.7% | — |
| CABA | $220M | -1.0 | — | — | -115.5% | — |
| KYTX | $568M | -2.6 | — | — | -77.4% | — |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | — |
| RIGL | $784M | 2.2 | 64.1% | 124.7% | 155.1% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 13
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $47M | $14M | $15M | $26M | $23M | $9M | |
| SG&A Expense | $21M | $16M | $25M | $19M | $12M | $2M | |
| Operating Expenses | $68M | $82M | $40M | $45M | $36M | $21M | |
| Operating Income | $-68M | $-82M | $-40M | $-45M | $-36M | $-21M | |
| Interest Income | $8M | $8M | $5M | · | · | · | |
| Other Non-op | $8M | $8M | $5M | $-109.0K | $-12M | $257.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-60M | $-74M | $-35M | $-45M | $-47M | $-21M | |
| EPS (Basic) | $-0.88 | $-1.53 | $-1.30 | $-1.72 | $-4.24 | · | |
| EPS (Diluted) | $-0.88 | $-1.53 | $-1.30 | $-1.72 | $-4.24 | · | |
| Shares (Basic) | 67,812,145 | 48,163,301 | 26,987,122 | 26,311,554 | 12,260,551 | · | |
| Shares (Diluted) | 67,812,145 | 48,163,301 | 26,987,122 | 26,311,554 | 12,260,551 | 2,187,813 | |
| EBITDA | $-68M | $-82M | · | $-45M | $-36M | · |
Balance Sheet 19
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $36M | $87M | $93M | $44M | $47M | $20M | |
| Short-term Investments | $65M | $64M | $14M | $80M | $90M | $0 | |
| Prepaid Expense | $5M | $4M | $3M | $11M | $12M | $2M | |
| Current Assets | $106M | $155M | $110M | $134M | $148M | $22M | |
| PP&E (Net) | $288.0K | $199.0K | · | · | · | · | |
| Other Non-current Assets | $2M | $16.0K | $15.0K | $128.0K | $70.0K | $3M | |
| Total Assets | $168M | $217M | $110M | $135M | $173M | $25M | |
| Accounts Payable | $2M | $705.0K | $66.0K | $750.0K | $1M | $1M | |
| Accrued Liabilities | · | $4M | $2M | $5M | $5M | $1M | |
| Current Liabilities | $7M | $5M | $3M | $6M | $6M | $3M | |
| Capital Leases | $285.0K | $375.0K | $15.0K | $180.0K | $0 | · | |
| Other Non-current Liabilities | · | $0 | $22.0K | $0 | $7.0K | $0 | |
| Total Liabilities | $7M | $5M | $3M | $6M | $6M | $3M | |
| Common Stock | $5.0K | $7.0K | $3.0K | $3.0K | $3.0K | $1.0K | |
| Retained Earnings | $-290M | $-230M | $-156M | $-121M | $-76M | $-28M | |
| AOCI | $435.0K | $23.0K | $-2.0K | $-358.0K | $-123.0K | $0 | |
| Stockholders' Equity | $160M | $212M | $108M | $129M | $167M | $-25M | |
| Liabilities + Equity | $168M | $217M | $110M | $135M | $173M | $25M | |
| Shares Outstanding | 47,766,338 | 67,255,434 | 27,699,446 | 26,567,681 | 26,567,681 | 3,418,751 |
Cash Flow 11
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $97.0K | $0 | · | · | · | · | |
| Stock-based Comp | $8M | $6M | $13M | $7M | $4M | $707.0K | |
| Other Non-cash | $-3M | · | · | · | · | · | |
| Operating Cash Flow | $-54M | $-16M | $-21M | $-37M | $-36M | $-14M | |
| CapEx | $186.0K | $0 | $0 | · | · | · | |
| Investing Cash Flow | $3M | $-121M | $69M | $34M | $-115M | $8M | |
| Stock Issued | · | $11M | $841.0K | $0 | $149.0K | · | |
| Net Stock Activity | · | $11M | · | · | $149.0K | · | |
| Financing Cash Flow | $-21.0K | $131M | $841.0K | $0 | $177M | $5M | |
| Net Change in Cash | $-52M | $-6M | $50M | $-3M | $26M | $-736.0K | |
| Free Cash Flow | $-55M | $-20M | · | · | · | · |
Profitability 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -31.1% | -45.1% | · | -29.4% | -48.0% | · | |
| ROE | -34.6% | -34.3% | · | -34.4% | -27.6% | · |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 15.2 | 31.4 | · | 22.0 | 24.6 | · | |
| Quick Ratio | 14.5 | 30.6 | · | 20.3 | 22.6 | · |
Valuation (TTM) 8
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-60M | $-74M | $-35M | $-45M | $-47M | · | |
| Market Cap | $191M | $121M | · | $98M | $274M | · | |
| P/E | -4.5 | -1.2 | -2.1 | -2.1 | -2.5 | · | |
| P/B | 1.2 | 0.6 | · | 0.8 | 1.6 | · | |
| P / Tangible Book | 1.2 | 0.6 | 0.7 | 0.8 | 1.6 | · | |
| P / Cash Flow | -3.5 | -7.8 | · | -2.6 | -7.6 | · | |
| P / FCF | -3.5 | -6.0 | · | · | · | · | |
| Earnings Yield | -22.0% | -85.0% | -48.1% | -46.9% | -40.5% | · |
Income Statement 13
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $9M | $14M | $9M | $7M | $17M | $6M | $6M | $1M | $1M | $3M | $3M | $4M | $6M | $5M | $4M | $9M | |
| SG&A Expense | $6M | $6M | $6M | $4M | $6M | $5M | $5M | $4M | $2M | $2M | $2M | $3M | $18M | $5M | $4M | $5M | |
| Operating Expenses | $15M | $19M | $15M | $11M | $23M | $11M | $12M | $56M | $3M | $5M | $5M | $7M | $23M | $10M | $9M | $14M | |
| Operating Income | $-15M | $-19M | $-15M | $-11M | $-23M | $-11M | $-12M | $-56M | $-3M | $-5M | $-5M | $-7M | $-23M | $-10M | $-9M | $-14M | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $1M | · | · | · | · | · | · | · | · | |
| Other Non-op | $1M | $2M | $2M | $2M | $2M | $2M | $3M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $-934.0K | $-895.0K | |
| Income Tax | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-14M | $-18M | $-13M | $-9M | $-21M | $-8M | $-9M | $-55M | $-2M | $-4M | $-4M | $-5M | $-22M | $-8M | $-10M | $-15M | |
| EPS (Basic) | $-0.20 | $-0.25 | $-0.19 | $-0.13 | $-0.31 | $0.47 | $-0.13 | $-1.81 | $-0.06 | $-0.12 | $-0.15 | $-0.19 | $-0.84 | $-0.48 | $-0.37 | $-0.37 | |
| EPS (Diluted) | $-0.20 | $-0.25 | $-0.19 | $-0.13 | $-0.31 | $0.47 | $-0.13 | $-1.81 | $-0.06 | $-0.12 | $-0.15 | $-0.19 | $-0.84 | $-0.48 | $-0.37 | $-0.37 | |
| Shares (Basic) | 68,207,313 | -135,238,674 | 68,003,248 | 67,585,121 | 67,462,450 | -76,838,972 | 67,014,183 | 30,349,562 | 27,638,528 | -53,416,924 | 27,071,053 | 26,840,555 | 26,492,438 | -52,559,985 | 26,336,029 | 26,296,560 | |
| Shares (Diluted) | 68,207,313 | -135,238,674 | 68,003,248 | 67,585,121 | 67,462,450 | -76,838,972 | 67,014,183 | 30,349,562 | 27,638,528 | -53,416,924 | 27,071,053 | 26,840,555 | 26,492,438 | -52,559,985 | 26,336,029 | 26,296,560 | |
| EBITDA | $-15M | · | $-15M | $-11M | $-23M | · | $-12M | $-56M | $-3M | · | $-5M | $-7M | $-23M | · | $-9M | $-14M |
Balance Sheet 19
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $36M | $26M | $23M | $29M | $87M | $146M | $223M | $105M | $93M | $57M | $25M | $34M | $44M | $36M | $33M | |
| Short-term Investments | $101M | $65M | $61M | $62M | $69M | $64M | $47M | $0 | $0 | $14M | $50M | $77M | $75M | $80M | $87M | $90M | |
| Prepaid Expense | $4M | $5M | $4M | $3M | $2M | $4M | $4M | $3M | $4M | $3M | $5M | $12M | $11M | $11M | $11M | $10M | |
| Current Assets | $113M | $106M | $91M | $87M | $100M | $155M | $198M | $226M | $109M | $110M | $112M | $114M | $120M | $134M | $133M | $133M | |
| PP&E (Net) | $250.0K | $288.0K | $318.0K | $314.0K | · | $199.0K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $2M | $2M | $2M | $1M | $226.0K | $16.0K | $0 | $0 | $0 | $15.0K | $15.0K | $2M | $1M | $128.0K | $141.0K | $5M | |
| Total Assets | $152M | $168M | $182M | $192M | $201M | $217M | $222M | $226M | $109M | $110M | $113M | $116M | $122M | $135M | $141M | $150M | |
| Accounts Payable | $860.0K | $2M | $477.0K | $946.0K | $777.0K | $705.0K | $291.0K | $509.0K | $85.0K | $66.0K | $736.0K | $878.0K | $864.0K | $750.0K | $1M | $1M | |
| Accrued Liabilities | · | · | · | · | $6M | · | $3M | $3M | $3M | $2M | $2M | $2M | $4M | $5M | $4M | $6M | |
| Current Liabilities | $4M | $7M | $5M | $6M | $7M | $5M | $3M | $4M | $3M | $3M | $3M | $4M | $5M | $6M | $6M | $8M | |
| Capital Leases | $216.0K | $285.0K | $352.0K | $417.0K | $319.0K | $375.0K | $0 | $0 | $0 | $15.0K | $58.0K | $100.0K | $223.0K | $180.0K | $219.0K | $256.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | $0 | $0 | $0 | $22.0K | $34.0K | $55.0K | $87.0K | $0 | $0 | $0 | |
| Total Liabilities | $4M | $7M | $5M | $7M | $7M | $5M | $3M | $4M | $3M | $3M | $3M | $4M | $5M | $6M | $6M | $8M | |
| Common Stock | $5.0K | $5.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Retained Earnings | $-303M | $-290M | $-272M | $-259M | $-251M | $-230M | $-221M | $-213M | $-158M | $-156M | $-152M | $-148M | $-143M | $-121M | $-113M | $-103M | |
| AOCI | $157.0K | $435.0K | $469.0K | $318.0K | $286.0K | $23.0K | $201.0K | $0 | $0 | $-2.0K | $-11.0K | $-35.0K | $-95.0K | $-358.0K | $-581.0K | $-604.0K | |
| Stockholders' Equity | $148M | $160M | $177M | $186M | $193M | $212M | $219M | $222M | $106M | $108M | $110M | $113M | $117M | $129M | $134M | $142M | |
| Liabilities + Equity | $152M | $168M | $182M | $192M | $201M | $217M | $222M | $226M | $109M | $110M | $113M | $116M | $122M | $135M | $141M | $150M | |
| Shares Outstanding | 47,768,543 | 47,766,338 | 68,184,435 | 67,764,100 | 67,575,767 | 67,255,434 | 67,223,760 | 66,785,449 | 27,723,824 | 27,699,446 | 27,466,005 | 26,994,988 | 26,973,875 | 26,567,681 | 26,567,681 | 26,567,681 |
Cash Flow 11
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $38.0K | $30.0K | $29.0K | $38.0K | $0 | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $2M | $1M | $4M | $1M | $2M | $2M | $3M | $512.0K | $465.0K | $1M | $656.0K | $777.0K | $10M | $2M | $2M | $2M | |
| Restructuring | · | · | · | · | · | · | · | · | $0 | $2M | $200.0K | $700.0K | $16M | · | · | · | |
| Other Non-cash | $-2M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-14M | $-16M | $-12M | $-11M | $-15M | $-6M | $-8M | $-667.0K | $-2M | $-947.0K | $3M | $-8M | $-15M | $-8M | $-4M | $-14M | |
| CapEx | · | $0 | $109.0K | · | · | $0 | $-5M | · | · | $0 | $0 | · | · | · | · | · | |
| Investing Cash Flow | $-13M | $26M | $15M | $5M | $-43M | $-53M | $-72M | $-10M | $14M | $37M | $28M | $-2M | $6M | $14M | $9M | $16M | |
| Stock Issued | · | · | · | · | $0 | · | $2M | $9M | $15.0K | $288.0K | $528.0K | $24.0K | $1.0K | $0 | $0 | $0 | |
| Net Stock Activity | · | · | · | · | $0 | · | · | · | $15.0K | · | · | · | $1.0K | · | · | · | |
| Financing Cash Flow | $5.0K | $-21.0K | $0 | $0 | $0 | $41.0K | $2M | $128M | $15.0K | $288.0K | $528.0K | $24.0K | $1.0K | $0 | $0 | $0 | |
| Net Change in Cash | $-27M | $10M | $3M | $-6M | $-58M | $-59M | $-77M | $118M | $12M | $36M | $32M | $-9M | $-9M | $8M | $3M | $671.0K |
Profitability 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -7.8% | · | -6.4% | -4.1% | -13.4% | · | -5.3% | -32.1% | -1.5% | · | -3.1% | -3.9% | -15.7% | · | -6.0% | -11.3% | |
| ROE | -8.0% | · | -6.5% | -4.2% | -13.9% | · | -5.4% | -32.8% | -1.5% | · | -3.2% | -4.1% | -16.4% | · | -6.2% | -31.9% |
Liquidity & Solvency 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 27.9 | · | 18.4 | 14.1 | 14.3 | · | 57.7 | 60.4 | 37.0 | · | 38.8 | 31.6 | 24.5 | · | 21.2 | 17.5 | |
| Quick Ratio | 26.9 | · | 17.6 | 13.7 | 13.9 | · | 56.5 | 59.6 | 35.6 | · | 37.0 | 28.4 | 22.3 | · | 19.5 | 16.1 |
Valuation (TTM) 7
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-56M | · | $-51M | $-93M | $-86M | · | $-69M | $-66M | $-33M | · | $-41M | $-52M | $-60M | · | $-47M | $-46M | |
| Market Cap | $327M | · | $137M | $84M | $82M | · | $342M | $475M | $76M | · | $72M | $76M | $78M | · | $86M | $80M | |
| P/E | -8.3 | · | -2.6 | -0.5 | -0.5 | · | -2.4 | -3.2 | -2.2 | · | -1.7 | -1.6 | -1.4 | · | -1.7 | -0.6 | |
| P/B | 2.2 | · | 0.8 | 0.5 | 0.4 | · | 1.6 | 2.1 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.6 | |
| P / Tangible Book | 2.2 | · | 0.8 | 0.5 | 0.4 | · | 1.6 | 2.1 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.6 | |
| P / Cash Flow | -22.8 | · | · | · | -5.3 | · | · | · | -41.8 | · | · | · | -5.2 | · | · | · | |
| Earnings Yield | -12.1% | · | -37.8% | -191.9% | -189.3% | · | -42.2% | -31.1% | -45.3% | · | -58.9% | -63.2% | -71.7% | · | -60.1% | -155.0% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Net Income | $-60M | $-74M | $-35M | $-45M | $-47M |
| Diluted EPS | $-0.88 | $-1.53 | $-1.30 | $-1.72 | $-4.24 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | 15.2 | 31.4 | — | 22.0 | 24.6 |
| Quick Ratio | 14.5 | 30.6 | — | 20.3 | 22.6 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $-55M | $-20M | — | — | — |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.